Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
Guardado en:
Autores principales: | Yi Dong, David Z Wang, Yi Sui, Xin Cheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f9e055995b540fba6ee499944639130 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Outcomes after Intravenous Alteplase in Elderly Patients with Acute Ischaemic Stroke: A Retrospective Analysis of Patients Treated at a Tertiary Neurology Centre in England from 2013 to 2018
por: Xuya Huang, et al.
Publicado: (2021) -
Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Lei Zhang, et al.
Publicado: (2021) -
Precision antiplatelet therapy for the prevention of ischaemic stroke
por: David Wang -
Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors
por: Laine Thomas, et al.
Publicado: (2021) -
Smoking influences outcome in patients who had thrombolysed ischaemic stroke: the ENCHANTED study
por: Thompson Robinson, et al.
Publicado: (2021)